Early tumor shrinkage and depth of response in patients with metastatic esophageal cancer treated with 2-weekly docetaxel combined with cisplatin plus fluorouracil: an exploratory analysis of the JCOG0807-Reference-Cited by-同舟云学术

Early tumor shrinkage and depth of response in patients with metastatic esophageal cancer treated with 2-weekly docetaxel combined with cisplatin plus fluorouracil: an exploratory analysis of the JCOG0807

Published:2022-11-22 Issue:2 Volume:20 Page:272-280
ISSN:1612-9059
Container-title:Esophagus
language:en
Short-container-title:Esophagus

Author:

Ura Takashi,Hironaka Shuichi^ORCID,Tsubosa Yasuhiro,Mizusawa Junki,Kato Ken,Tsushima Takahiro,Fushiki Kunihiro,Chin Keisho,Tomori Akihisa,Okuno Tatsuya,Matsushita Hisayuki,Kojima Takashi,Doki Yuichiro,Kusaba Hitoshi,Fujitani Kazumasa,Seki Shiko,Kitagawa Yuko

Funder

National cancer research and development fund

National cancer center research and development fund

National cancer center research and development

Grants-in-Aid for Cancer Research

Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

https://link.springer.com/content/pdf/10.1007/s10388-022-00968-9.pdf

Reference30 articles.

1. Vital Statistics Japan (Ministry of Health, Labour and Welfare). https://www.mhlw.go.jp/english/database/db-hw/vs01.html. Accessed 5 Jun 2022.

2. Matsuda A, Matsuda T, Shibata A, et al. Cancer incidence and incidence rates in Japan in 2007: a study of 21 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2013;43:328–36.

3. DeVita VT LT, Rosenberg SA. DeVita, Hellman, and Rosenberg’s Cancer: Principles & Practice of Oncology, 8th edition. 2008; 1032–56.

4. Iizuka T, Kakegawa T, Ide H, et al. Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japanese Esophageal Oncology Group Trial. Jpn J Clin Oncol. 1992;22:172–6.

5. Hayashi K, Ando N, Watanabe H, et al. Phase II evaluation of protracted infusion of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG) Trial (JCOG9407). Jpn J Clin Oncol. 2001;31:419–23.